Stock listing
Appili Therapeutics Inc Class A
Selected listing: APLI · TSX · CAD · CA
Appili Therapeutics Inc Class A (TSX:APLI), Health Technology. Latest release Sep 29, 2026: Appili Therapeutics Announces Transfer to NEX.
- Ticker
- TSX:APLI
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSX
- Currency
- CAD
About Appili Therapeutics Inc Class A
Appili Therapeutics Inc Class A, trading under the ticker APLI, is a public company based in Canada. Appili focuses on developing innovative therapies to address unmet medical needs.
Latest news from Appili Therapeutics Inc Class A
Appili Therapeutics Announces Transfer to NEX
September 29, 2026
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2027
August 14, 2026
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
July 3, 2026
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
June 26, 2026
Appili Therapeutics to Exhibit at World Vaccine Congress Washington
March 30, 2026
Research Appili Therapeutics Inc Class A
Appili Therapeutics Inc Class A company profile
View the public company page for Appili Therapeutics Inc Class A on 6ix.
Appili Therapeutics Inc Class A news
Read company news and market updates connected to Appili Therapeutics Inc Class A.
Appili Therapeutics Inc Class A investor events
Find investor webinars, events, and replay context for Appili Therapeutics Inc Class A.